Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Coronary Artery Disease: HELP
Daniel Gaudet
Based on 12 articles published since 2010
(Why 12 articles?)
||||
Expertise Level
The expertise of Daniel Gaudet ranks in the Graphical view (beta)
Work Locations
Details
Most likely:    Universite de Montreal      
2018
  • Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: · Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montréal, Quebec, Canada. · Department of Medicine, McGill University, Montréal, Quebec, Canada; Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montréal, Montréal, Quebec, Canada. · Faculty of Medicine, University of Toronto, Institute for Clinical Evaluative Sciences, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. · Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada. · Department of Medicine, McMaster University, Hamilton, and Canadian Collaborative Research Network, Brampton, Ontario, Canada. · Departments of Medicine and Laboratory Medicine, CHU de Québec-Université Laval, Québec City, Quebec, Canada. · Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Pediatrics, The Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. · Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada. · Department of Pediatrics, McGill University, Clinique 180, Montréal, Quebec, Canada. · Department of Pediatrics, Université de Montréal, CHU Sainte-Justine, Montréal, Quebec, Canada. · Departments of Medicine and Biochemistry, Schulich School of Medicine and Robarts Research Institute, Western University, London, Ontario, Canada. · Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montréal, Quebec, Canada; Department of Medicine, McGill University, Montréal, Quebec, Canada. · Department of Medicine, University of Toronto and Division of Endocrinology, St Michael's Hospital, Toronto Ontario, Canada. · Lipidology Unit, Community Genomic Medicine Centre and ECOGENE-21, Department of Medicine, Université de Montréal, Saguenay, Quebec, Canada. · Department of Pathology and Molecular Medicine, Department of Clinical Epidemiology and Biostatistics, Population Health Research Institute and Thrombosis and Atherosclerosis Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada. · Division of Endocrinology and Metabolism, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. · Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada. · Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montréal, Montréal, Quebec, Canada; Department of Medicine, Division of Endocrinology, Université de Montreal, Montréal, Quebec, Canada. · Department of Medicine, Section of Endocrinology and Metabolism, University of Manitoba, St Boniface Hospital, Winnipeg, Manitoba, Canada. · Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. · Division of Cardiology, Department of Medicine, Dalhousie University, St John, New Brunswick, Canada. · Pubmed 30527143
  • Cardiometabolics Unit, Icahn School of Medicine at Mount Sinai, Hospital Box 1030, One Gustave L. Levy Place, New York, New York 10029, USA. · Medstar Heart and Vascular Institute, Washington Hospital Center, 110 Irving Street NW, Washington, DC 20010, USA. · School of Medical Sciences, Faculty of Medicine, Level 4E, Wallace Wurth Building, University of New South Wales Sydney, 18 High Street, Sydney, Kensington New South Wales 2052, Australia. · Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, USA. · Integrated Cardio Metabolic Centre, Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset, 171 77 Huddinge, Sweden. · National Institute for Health and Medical Research (INSERM) and Endocrinology Metabolism Service, Pitie-Salpetriere University Hospital, 83 Boulevard de l'Hôpital, 75651 Paris, France. · Lipidology Unit, Community Genomic Medicine Centre and ECOGENE-21, Department of Medicine, Université de Montréal, 930 Jacques-Cartier, Saguenay, Québec G7H 7K9, Canada. · University of Michigan School of Public Health, M4045 SPH II, 1415 Washington Heights, Ann Arbor, Michigan 48109-2029, USA. · Hartis-Pharma Sàrl, 13c Chemin de Bonmont, 1260 Nyon, Switzerland. · Nutrition Department, Harvard T. H. Chan School of Public Health, 665 Huntington Avenue, Boston, Massachusetts 02478, USA. · Montreal Heart Institute, Université de Montréal, 5000 Belanger Street, Montréal, Québec H1T 1C8, Canada. · Department of Medicine and Robarts Research Institute, Western University, 4288A-1151 Richmond Street North, London, Ontario N6A 5B7, Canada. · Pubmed 28795686
  • Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada. Electronic address: · Lipidology Unit, Community Genomic Medicine Centre and ECOGENE-21, Department of Medicine, Université de Montréal, Saguenay, Quebec, Canada. · Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada. · Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. · Division of Experimental Medicine and Medical Biochemistry, Department of Medicine, McGill University, Quebec, Canada; Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montréal, Quebec, Canada. · Lipid Research Centre, CHU de Québec-Université Laval, Québec City, Quebec, Canada. · Division of Cardiology, Department of Medicine, Dalhousie University, St John, New Brunswick, Canada. · Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada; Department of Medicine, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada. · Healthy Heart Program Prevention Clinic, St Paul's Hospital, Vancouver, British Columbia, Canada, Department of Medicine, University of British Columbia, Vancouver, British Columbia, and Centre for Heart Lung Innovation, Providence Health Care Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. · Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montréal, Quebec, Canada, Department of Nutrition, Université de Montréal, Quebec, Canada. · Healthy Heart Program Prevention Clinic, St Paul's Hospital, Vancouver, British Columbia, Canada, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Montreal Heart Institute, Montreal, Quebec, Canada. · McMaster University, Hamilton, Ontario, Canada, Canadian Collaborative Research Network, Brampton, Ontario, Canada. · Departments of Medicine and Biochemistry, Schulich School of Medicine and Robarts Research Institute, Western University, London, Ontario, Canada. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Division of Cardiology, The Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Ontario, Canada. · School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia. · Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada. · Faculty of Medicine, University of Toronto, Institute for Clinical Evaluative Sciences, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. · School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia; Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Australia. · Pubmed 30093300
  • Lipidology Unit, Community Genomic Medicine Center, Department of Medicine, Université de Montréal and ECOGENE-21 Clinical and Translational Research Center, 225 St-Vallier Chicoutimi, Québec, G7H 7P2, Canada. · Lipidology Unit, Community Genomic Medicine Center, Department of Medicine, Université de Montréal and ECOGENE-21 Clinical and Translational Research Center, 225 St-Vallier Chicoutimi, Québec, G7H 7P2, Canada. · Pubmed 30053852
2016
  • Department of Biochemistry, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada. · ECOGENE-21 & Lipid Clinic, Chicoutimi Hospital, Saguenay, QC G7H 5H6, Canada. · Department of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada. · Centre de recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC G1V 0A6, Canada. · Department of Molecular Medicine, Université Laval, Québec, QC G1V 0A6, Canada. · Pubmed 26950807
2015
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: · Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Cardiovascular Trials Unit, Central Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom. · Department of Vascular Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. · Lipid Clinic, Department of Medicine, Université de Montreal, Chicoutimi, Quebec, Canada. · Cerenis Therapeutics Holdings, Toulouse, France. · Pubmed 25965722
2014
  • Department of Biochemistry; Université de Sherbrooke; Sherbrooke, QC Canada; ECOGENE-21 and Lipid Clinic; Chicoutimi Hospital; Saguenay, QC Canada. · ECOGENE-21 and Lipid Clinic; Chicoutimi Hospital; Saguenay, QC Canada; Department of Medicine; Université de Montréal; Montréal, QC Canada. · Institute of Nutrition and Functional Foods; Université Laval; Québec, QC Canada. · Pubmed 24504152
Probable:    Miscellaneous cities in Canada      
2016
  • Department of Biochemistry, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada. · ECOGENE-21 & Lipid Clinic, Chicoutimi Hospital, Saguenay, QC G7H 5H6, Canada. · Department of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada. · Centre de recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC G1V 0A6, Canada. · Department of Molecular Medicine, Université Laval, Québec, QC G1V 0A6, Canada. · Pubmed 26950807
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by Daniel Gaudet about Coronary Artery Disease:

  • Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018. 2018
  • HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology. 2018
  • Simplified Canadian Definition for Familial Hypercholesterolemia. 2018
  • Association study between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and metabolic syndrome. 2018
  • Epigenetic and genetic variations at the TNNT1 gene locus are associated with HDL-C levels and coronary artery disease. 2016
  • The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study. 2015
  • A study in familial hypercholesterolemia suggests reduced methylomic plasticity in men with coronary artery disease. 2015
  • Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia. 2014
  • Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease. 2012
  • Angiographically-assessed coronary artery disease associates with HDL particle size in women. 2012
Show List of Full Article Records
Google Searches

Learn more about Daniel Gaudet using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universite de Montreal
Miscellaneous cities in Canada
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universite de Montreal
2018
  • Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: · Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montréal, Quebec, Canada. · Department of Medicine, McGill University, Montréal, Quebec, Canada; Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montréal, Montréal, Quebec, Canada. · Faculty of Medicine, University of Toronto, Institute for Clinical Evaluative Sciences, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. · Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada. · Department of Medicine, McMaster University, Hamilton, and Canadian Collaborative Research Network, Brampton, Ontario, Canada. · Departments of Medicine and Laboratory Medicine, CHU de Québec-Université Laval, Québec City, Quebec, Canada. · Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Pediatrics, The Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. · Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada. · Department of Pediatrics, McGill University, Clinique 180, Montréal, Quebec, Canada. · Department of Pediatrics, Université de Montréal, CHU Sainte-Justine, Montréal, Quebec, Canada. · Departments of Medicine and Biochemistry, Schulich School of Medicine and Robarts Research Institute, Western University, London, Ontario, Canada. · Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montréal, Quebec, Canada; Department of Medicine, McGill University, Montréal, Quebec, Canada. · Department of Medicine, University of Toronto and Division of Endocrinology, St Michael's Hospital, Toronto Ontario, Canada. · Lipidology Unit, Community Genomic Medicine Centre and ECOGENE-21, Department of Medicine, Université de Montréal, Saguenay, Quebec, Canada. · Department of Pathology and Molecular Medicine, Department of Clinical Epidemiology and Biostatistics, Population Health Research Institute and Thrombosis and Atherosclerosis Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada. · Division of Endocrinology and Metabolism, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. · Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada. · Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montréal, Montréal, Quebec, Canada; Department of Medicine, Division of Endocrinology, Université de Montreal, Montréal, Quebec, Canada. · Department of Medicine, Section of Endocrinology and Metabolism, University of Manitoba, St Boniface Hospital, Winnipeg, Manitoba, Canada. · Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. · Division of Cardiology, Department of Medicine, Dalhousie University, St John, New Brunswick, Canada. · Pubmed 30527143
  • Cardiometabolics Unit, Icahn School of Medicine at Mount Sinai, Hospital Box 1030, One Gustave L. Levy Place, New York, New York 10029, USA. · Medstar Heart and Vascular Institute, Washington Hospital Center, 110 Irving Street NW, Washington, DC 20010, USA. · School of Medical Sciences, Faculty of Medicine, Level 4E, Wallace Wurth Building, University of New South Wales Sydney, 18 High Street, Sydney, Kensington New South Wales 2052, Australia. · Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, USA. · Integrated Cardio Metabolic Centre, Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset, 171 77 Huddinge, Sweden. · National Institute for Health and Medical Research (INSERM) and Endocrinology Metabolism Service, Pitie-Salpetriere University Hospital, 83 Boulevard de l'Hôpital, 75651 Paris, France. · Lipidology Unit, Community Genomic Medicine Centre and ECOGENE-21, Department of Medicine, Université de Montréal, 930 Jacques-Cartier, Saguenay, Québec G7H 7K9, Canada. · University of Michigan School of Public Health, M4045 SPH II, 1415 Washington Heights, Ann Arbor, Michigan 48109-2029, USA. · Hartis-Pharma Sàrl, 13c Chemin de Bonmont, 1260 Nyon, Switzerland. · Nutrition Department, Harvard T. H. Chan School of Public Health, 665 Huntington Avenue, Boston, Massachusetts 02478, USA. · Montreal Heart Institute, Université de Montréal, 5000 Belanger Street, Montréal, Québec H1T 1C8, Canada. · Department of Medicine and Robarts Research Institute, Western University, 4288A-1151 Richmond Street North, London, Ontario N6A 5B7, Canada. · Pubmed 28795686
  • Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada. Electronic address: · Lipidology Unit, Community Genomic Medicine Centre and ECOGENE-21, Department of Medicine, Université de Montréal, Saguenay, Quebec, Canada. · Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada. · Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. · Division of Experimental Medicine and Medical Biochemistry, Department of Medicine, McGill University, Quebec, Canada; Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montréal, Quebec, Canada. · Lipid Research Centre, CHU de Québec-Université Laval, Québec City, Quebec, Canada. · Division of Cardiology, Department of Medicine, Dalhousie University, St John, New Brunswick, Canada. · Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada; Department of Medicine, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada. · Healthy Heart Program Prevention Clinic, St Paul's Hospital, Vancouver, British Columbia, Canada, Department of Medicine, University of British Columbia, Vancouver, British Columbia, and Centre for Heart Lung Innovation, Providence Health Care Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. · Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montréal, Quebec, Canada, Department of Nutrition, Université de Montréal, Quebec, Canada. · Healthy Heart Program Prevention Clinic, St Paul's Hospital, Vancouver, British Columbia, Canada, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Montreal Heart Institute, Montreal, Quebec, Canada. · McMaster University, Hamilton, Ontario, Canada, Canadian Collaborative Research Network, Brampton, Ontario, Canada. · Departments of Medicine and Biochemistry, Schulich School of Medicine and Robarts Research Institute, Western University, London, Ontario, Canada. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Division of Cardiology, The Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Ontario, Canada. · School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia. · Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada. · Faculty of Medicine, University of Toronto, Institute for Clinical Evaluative Sciences, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. · School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia; Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Australia. · Pubmed 30093300
  • Lipidology Unit, Community Genomic Medicine Center, Department of Medicine, Université de Montréal and ECOGENE-21 Clinical and Translational Research Center, 225 St-Vallier Chicoutimi, Québec, G7H 7P2, Canada. · Lipidology Unit, Community Genomic Medicine Center, Department of Medicine, Université de Montréal and ECOGENE-21 Clinical and Translational Research Center, 225 St-Vallier Chicoutimi, Québec, G7H 7P2, Canada. · Pubmed 30053852
2016
  • Department of Biochemistry, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada. · ECOGENE-21 & Lipid Clinic, Chicoutimi Hospital, Saguenay, QC G7H 5H6, Canada. · Department of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada. · Centre de recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC G1V 0A6, Canada. · Department of Molecular Medicine, Université Laval, Québec, QC G1V 0A6, Canada. · Pubmed 26950807
2015
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: · Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Cardiovascular Trials Unit, Central Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom. · Department of Vascular Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. · Lipid Clinic, Department of Medicine, Université de Montreal, Chicoutimi, Quebec, Canada. · Cerenis Therapeutics Holdings, Toulouse, France. · Pubmed 25965722
2014
  • Department of Biochemistry; Université de Sherbrooke; Sherbrooke, QC Canada; ECOGENE-21 and Lipid Clinic; Chicoutimi Hospital; Saguenay, QC Canada. · ECOGENE-21 and Lipid Clinic; Chicoutimi Hospital; Saguenay, QC Canada; Department of Medicine; Université de Montréal; Montréal, QC Canada. · Institute of Nutrition and Functional Foods; Université Laval; Québec, QC Canada. · Pubmed 24504152
Miscellaneous cities in Canada
2016
  • Department of Biochemistry, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada. · ECOGENE-21 & Lipid Clinic, Chicoutimi Hospital, Saguenay, QC G7H 5H6, Canada. · Department of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada. · Centre de recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC G1V 0A6, Canada. · Department of Molecular Medicine, Université Laval, Québec, QC G1V 0A6, Canada. · Pubmed 26950807
3 Other Locations Show
Yearly article counts 00401210400
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.